3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
9
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Down Syndrome
3
Lymphoma, Mantle-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Smoldering Multiple Myeloma
1
Recurrence
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Hairy Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Hypersensitivity
1
Dyspnea
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
12
fludarabine
7
Vincristine
4
Rituximab
4
Prednisone
4
Doxorubicin
4
polatuzumab vedotin
3
Specimen Handling
3
zanubrutinib
2
pirtobrutinib
2
obinutuzumab
2
glofitamab
2
cemiplimab
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Cell- and Tissue-Based Therapy
2
Biopsy
2
Bendamustine Hydrochloride
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
loncastuximab tesirine
1
ibrutinib
1
iberdomide
1
fludarabine phosphate
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Calcium Dobesilate
×
30 days
×
Clear all
No trials found.